Cargando…
Acute Profound Thrombocytopenia Induced by Eptifibatide Causing Diffuse Alveolar Hemorrhage
BACKGROUND: Eptifibatide is a glycoprotein IIb/IIIa (GP IIb/IIIa) receptor inhibitor which prevents platelet activation. The mechanism in which eptifibatide causes profound thrombocytopenia is poorly understood. One hypothesis suggests antibody-dependent pathways which cause thrombocytopenia upon su...
Autores principales: | Byrd, Gregory, Custovic, Sabina, Byrd, David, Ingrassia Miano, Deanna, Bathla, Jasdeep, Attallah, Antonious |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302401/ https://www.ncbi.nlm.nih.gov/pubmed/34327026 http://dx.doi.org/10.1155/2021/8817067 |
Ejemplares similares
-
Profound thrombocytopenia after primary exposure to eptifibatide
por: Norgard, Nicholas B, et al.
Publicado: (2010) -
Eptifibatide-induced acute profound thrombocytopenia: a case report
por: Graidis, Christos, et al.
Publicado: (2014) -
Acute Stent Thrombosis Associated with Eptifibatide-Induced Profound Thrombocytopenia
por: Aljundi, Amer, et al.
Publicado: (2020) -
Eptifibatide-induced acute profound thrombocytopenia: A case report
por: Alamin, Mohammed A., et al.
Publicado: (2022) -
A rare case of eptifibatide-induced thrombocytopenia
por: Kamar, Khalil, et al.
Publicado: (2021)